289 related articles for article (PubMed ID: 30231335)
1. The Epigenetic Landscape in the Treatment of Gynecologic Malignancies.
Eskander RN
Am Soc Clin Oncol Educ Book; 2018 May; 38():480-487. PubMed ID: 30231335
[TBL] [Abstract][Full Text] [Related]
2. Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.
Duenas-Gonzalez A; Medina-Franco JL; Chavez-Blanco A; Dominguez-Gomez G; Fernández-de Gortari E
Expert Opin Pharmacother; 2016; 17(3):323-38. PubMed ID: 26559668
[TBL] [Abstract][Full Text] [Related]
3. Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies.
Vaidya AP; Parnes AD; Seiden MV
Curr Treat Options Oncol; 2005 Mar; 6(2):103-14. PubMed ID: 15717992
[TBL] [Abstract][Full Text] [Related]
4. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
Muggia FM
Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for gynecologic malignancies.
Vermorken JB; Hoekman K
Curr Opin Oncol; 1995 Sep; 7(5):457-65. PubMed ID: 8541392
[TBL] [Abstract][Full Text] [Related]
6. CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies.
Sun C; Duan P; Luan C
Curr Drug Targets; 2017; 18(10):1142-1151. PubMed ID: 28031014
[TBL] [Abstract][Full Text] [Related]
7. Current status of chemotherapy in gynecologic cancer.
Tropé C; Kristensen G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
[No Abstract] [Full Text] [Related]
8. Targeted therapy in gynecologic cancers: Ready for prime time?
Seoud M; Lundqvist EÅ; Fujiwara K
Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 2():S150-2. PubMed ID: 26433672
[No Abstract] [Full Text] [Related]
9. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapies in Gynecologic Cancer.
Bejar FG; Oaknin A; Williamson C; Mayadev J; Peters PN; Secord AA; Wield AM; Coffman LG
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-17. PubMed ID: 35594502
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in gynecologic cancer.
Sabbatini P; Aghajanian C; Spriggs D
Curr Opin Oncol; 1998 Sep; 10(5):429-33. PubMed ID: 9800113
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic therapy for ovarian cancer: promise and progress.
Moufarrij S; Dandapani M; Arthofer E; Gomez S; Srivastava A; Lopez-Acevedo M; Villagra A; Chiappinelli KB
Clin Epigenetics; 2019 Jan; 11(1):7. PubMed ID: 30646939
[TBL] [Abstract][Full Text] [Related]
13. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
14. Methylation of p16INK4A in primary gynecologic malignancy.
Wong YF; Chung TK; Cheung TH; Nobori T; Yu AL; Yu J; Batova A; Lai KW; Chang AM
Cancer Lett; 1999 Mar; 136(2):231-5. PubMed ID: 10355753
[TBL] [Abstract][Full Text] [Related]
15. Involvement of autophagy in cervical, endometrial and ovarian cancer.
Orfanelli T; Jeong JM; Doulaveris G; Holcomb K; Witkin SS
Int J Cancer; 2014 Aug; 135(3):519-28. PubMed ID: 24122662
[TBL] [Abstract][Full Text] [Related]
16. The role of the HER-2/neu oncogene in gynecologic cancers.
Cirisano FD; Karlan BY
J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
[TBL] [Abstract][Full Text] [Related]
17. The molecular genetics of gyn malignancies.
Taylor RR; Teneriello MG; Nash JD; Park RC; Birrer MJ
Oncology (Williston Park); 1994 Oct; 8(10):63-70, 73; discussion 73, 78-82. PubMed ID: 7803216
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of gynecologic cancer.
Whang JD; Lee JH
J Korean Med Sci; 1997 Oct; 12(5):383-9. PubMed ID: 9364294
[TBL] [Abstract][Full Text] [Related]
19. Ploidy in gynaecological cancers.
Fox H
Histopathology; 2005 Feb; 46(2):121-9. PubMed ID: 15693883
[No Abstract] [Full Text] [Related]
20. Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers.
Wolford JE; Ferrigni E; Margul D; Herzog TJ
Curr Oncol Rep; 2022 Jul; 24(7):889-904. PubMed ID: 35347591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]